Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2008 3
2009 3
2010 1
2011 1
2014 2
2015 4
2016 1
2017 3
2018 3
2019 1
2020 5
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
DNA damage foci: Meaning and significance.
Rothkamm K, Barnard S, Moquet J, Ellender M, Rana Z, Burdak-Rothkamm S. Rothkamm K, et al. Among authors: burdak rothkamm s. Environ Mol Mutagen. 2015 Jul;56(6):491-504. doi: 10.1002/em.21944. Epub 2015 Mar 12. Environ Mol Mutagen. 2015. PMID: 25773265 Review.
DNA Damage Repair Deficiency in Prostate Cancer.
Burdak-Rothkamm S, Mansour WY, Rothkamm K. Burdak-Rothkamm S, et al. Trends Cancer. 2020 Nov;6(11):974-984. doi: 10.1016/j.trecan.2020.05.011. Epub 2020 Jun 6. Trends Cancer. 2020. PMID: 32517958 Review.
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.
Elsesy ME, Oh-Hohenhorst SJ, Oing C, Eckhardt A, Burdak-Rothkamm S, Alawi M, Müller C, Schüller U, Maurer T, von Amsberg G, Petersen C, Rothkamm K, Mansour WY. Elsesy ME, et al. Among authors: burdak rothkamm s. Mol Oncol. 2023 Jun;17(6):1129-1147. doi: 10.1002/1878-0261.13382. Epub 2023 Mar 16. Mol Oncol. 2023. PMID: 36694344 Free PMC article.
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl FR, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki JR, Lohse AW, Schrader J. Benten D, et al. Among authors: burdak rothkamm s. Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12. Mol Cancer Res. 2018. PMID: 29330294
PINCER (A Platform Study for solId orgaN CancERs): an agile pan-network platform study to deliver high-quality translational research.
Jones RP, Mielgo A, Schmid M, Bury D, Andrews T, Burdak-Rothkamm S, Shackcloth M, J S Cross T, Fenwick S, Malik HZ, Diaz-Nieto R, Ottensmeier C, Palmer DH, Vimalachandran D. Jones RP, et al. Among authors: burdak rothkamm s. Br J Surg. 2023 Aug 11;110(9):1108-1111. doi: 10.1093/bjs/znad097. Br J Surg. 2023. PMID: 37075549 Free PMC article. No abstract available.
Radioprotection of targeted and bystander cells by methylproamine.
Burdak-Rothkamm S, Smith A, Lobachevsky P, Martin R, Prise KM. Burdak-Rothkamm S, et al. Strahlenther Onkol. 2015 Mar;191(3):248-55. doi: 10.1007/s00066-014-0751-9. Epub 2014 Sep 23. Strahlenther Onkol. 2015. PMID: 25245467 Free PMC article.
28 results